Vedolizumab for the Treatment of Collagenous Gastritis | MicrobiomeTrials← Back to trialsNCT06317220
Vedolizumab for the Treatment of Collagenous Gastritis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-12-03Est. Completion: 2026-02-17
Enrollment target: 11 participants Locations- Massachusetts General Hospital, Boston, Massachusetts, United States